Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade

Published:2024-06 Issue: Volume:209 Page:115306
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Choi Youngjin,Seok Su Hyun,Yoon Hong Yeol,Ryu Ju Hee,Kwon Ick Chan

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Korea Ministry of Health and Welfare

Publisher

Elsevier BV

Reference178 articles.

1. Cancer immunotherapy: it's time to better predict patients' response;Pilard;Br J Cancer,2021

2. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs;Haslam;JAMA Netw Open,2020

3. Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response;Wang;Signal Transduct Target Ther,2022

4. Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends;Sun;Signal Transduct Target Ther,2023

5. RNAi-based therapeutics and tumor targeted delivery in cancer;Kara;Adv Drug Deliv Rev,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Coding RNAs and Innate Immune Responses in Cancer;Biomedicines;2024-09-11

2. Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer;Pharmaceutics;2024-09-07

3. Integrated bioinformatics analysis and validation identify KIR2DL4 as a novel biomarker for predicting chemotherapy resistance and prognosis in Colorectal Cancer;Heliyon;2024-09

4. Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment;Pharmaceutics;2024-08-01

5. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3